Hecaray Secures Strategic Investment from Song Lin to Bring Cardiovascular AI Hardware to Homes
创业邦 · wechat · 2026-08-05
Cardiovascular AI startup Hecaray announced a comprehensive strategic partnership and investment from A-share listed company Song Lin Technology.
Leveraging Song Lin's global channels and manufacturing, the collaboration aims to bring Hecaray's clinical data-driven, millimeter-wave radar-based medical AI models into home scenarios. Hecaray's contactless monitoring tech currently identifies arrhythmias like atrial fibrillation with high accuracy and is advancing productizing continuous blood pressure tracking. Targeting 1M device shipments in 3 years, they aim to build a closed-loop home health management ecosystem.
More from Venture
- Chinese AI Startup Lovart Reportedly Explores Hong Kong IPO — Polymarket · 2026-08-05
- Indie Hacking Reflection: Long-term Commitment Beats Chasing Quick Wins — alexmacgregor__ · 2026-08-05
- Why Healthcare Giants Like Andon Health Are Becoming Key AI Investors — 创业邦 · 2026-08-05
- Airtable Acquisition Takeaway: Don't Raise More Capital Than You Actually Need — JosephJacks_ · 2026-08-05
- Vibe Coding Strategy: Use AI-Generated SaaS as a Funnel for Services — petergyang · 2026-08-05
- Palantir Solves Enterprise AI Context Problem with Zero Customer Churn, Analyst Says — eliano · 2026-08-05